DUCTAL CARCINOMA

Clinical trials for DUCTAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new DUCTAL CARCINOMA trials appear

Sign up with your email to follow new studies for DUCTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Can a 'Baby' dose of hormone drugs prevent breast cancer without side effects?

Prevention Not yet recruiting

This study compares two low-dose hormone drugs, exemestane and tamoxifen, in 140 postmenopausal women at high risk for breast cancer. The goal is to see which drug better maintains quality of life while reducing cancer risk. Participants will take the assigned drug for 12 months,…

Matched conditions: DUCTAL CARCINOMA

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention

Last updated May 15, 2026 11:56 UTC

DUCTAL CARCINOMA

Get alerted when new DUCTAL CARCINOMA trials appear

Can a 'Baby' dose of hormone drugs prevent breast cancer without side effects?